The global Autoimmune Disease Therapeutics market was valued at US$ 98160 million in 2023 and is anticipated to reach US$ 119350 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.

Autoimmune Disease Therapeutics Market

North American market for Autoimmune Disease Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Autoimmune Disease Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Autoimmune Disease Therapeutics in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Autoimmune Disease Therapeutics include Pfizer, Novartis, Johnson & Johnson Services, Merck, Sanofi, Abott, Bristol-Myers Squibb, Amgen and Bayer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Autoimmune Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disease Therapeutics.

Report Scope

The Autoimmune Disease Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autoimmune Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Autoimmune Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Autoimmune Disease Therapeutics Market Report

Report Metric	Details
Report Name	Autoimmune Disease Therapeutics Market
Accounted market size in 2023	US$ 98160 million
Forecasted market size in 2030	US$ 119350 million
CAGR	2.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Immunosuppressants Anti-Inflammatory Drugs Corticosteroids Nonsteroidal Anti-inflammatory Drugs Biologics Others
Segment by Application	Hospitals Clinics Independent Pharmacies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Novartis, Johnson & Johnson Services, Merck, Sanofi, Abott, Bristol-Myers Squibb, Amgen, Bayer, F. Hoffmann-La Roche, Eli Lilly and Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autoimmune Disease Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Autoimmune Disease Therapeutics Market growing?

Ans: The Autoimmune Disease Therapeutics Market witnessing a CAGR of 2.4% during the forecast period 2024-2030.

What is the Autoimmune Disease Therapeutics Market size in 2030?

Ans: The Autoimmune Disease Therapeutics Market size in 2030 will be US$ 119350 million.

Who are the main players in the Autoimmune Disease Therapeutics Market report?

Ans: The main players in the Autoimmune Disease Therapeutics Market are Pfizer, Novartis, Johnson & Johnson Services, Merck, Sanofi, Abott, Bristol-Myers Squibb, Amgen, Bayer, F. Hoffmann-La Roche, Eli Lilly and Company

What are the Application segmentation covered in the Autoimmune Disease Therapeutics Market report?

Ans: The Applications covered in the Autoimmune Disease Therapeutics Market report are Hospitals, Clinics, Independent Pharmacies, Others

What are the Type segmentation covered in the Autoimmune Disease Therapeutics Market report?

Ans: The Types covered in the Autoimmune Disease Therapeutics Market report are Immunosuppressants, Anti-Inflammatory Drugs, Corticosteroids, Nonsteroidal Anti-inflammatory Drugs, Biologics, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Autoimmune Disease Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Immunosuppressants

1.2.3 Anti-Inflammatory Drugs

1.2.4 Corticosteroids

1.2.5 Nonsteroidal Anti-inflammatory Drugs

1.2.6 Biologics

1.2.7 Others

1.3 Market by Application

1.3.1 Global Autoimmune Disease Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Independent Pharmacies

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Autoimmune Disease Therapeutics Market Perspective (2019-2030)

2.2 Autoimmune Disease Therapeutics Growth Trends by Region

2.2.1 Global Autoimmune Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Autoimmune Disease Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Autoimmune Disease Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Autoimmune Disease Therapeutics Market Dynamics

2.3.1 Autoimmune Disease Therapeutics Industry Trends

2.3.2 Autoimmune Disease Therapeutics Market Drivers

2.3.3 Autoimmune Disease Therapeutics Market Challenges

2.3.4 Autoimmune Disease Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Autoimmune Disease Therapeutics Players by Revenue

3.1.1 Global Top Autoimmune Disease Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Autoimmune Disease Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Autoimmune Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Autoimmune Disease Therapeutics Revenue

3.4 Global Autoimmune Disease Therapeutics Market Concentration Ratio

3.4.1 Global Autoimmune Disease Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Therapeutics Revenue in 2023

3.5 Autoimmune Disease Therapeutics Key Players Head office and Area Served

3.6 Key Players Autoimmune Disease Therapeutics Product Solution and Service

3.7 Date of Enter into Autoimmune Disease Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Autoimmune Disease Therapeutics Breakdown Data by Type

4.1 Global Autoimmune Disease Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Autoimmune Disease Therapeutics Forecasted Market Size by Type (2025-2030)

5 Autoimmune Disease Therapeutics Breakdown Data by Application

5.1 Global Autoimmune Disease Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Autoimmune Disease Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Autoimmune Disease Therapeutics Market Size (2019-2030)

6.2 North America Autoimmune Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Autoimmune Disease Therapeutics Market Size by Country (2019-2024)

6.4 North America Autoimmune Disease Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Autoimmune Disease Therapeutics Market Size (2019-2030)

7.2 Europe Autoimmune Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Autoimmune Disease Therapeutics Market Size by Country (2019-2024)

7.4 Europe Autoimmune Disease Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Autoimmune Disease Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Autoimmune Disease Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Autoimmune Disease Therapeutics Market Size (2019-2030)

9.2 Latin America Autoimmune Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Autoimmune Disease Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Autoimmune Disease Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Autoimmune Disease Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Autoimmune Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Autoimmune Disease Therapeutics Introduction

11.1.4 Pfizer Revenue in Autoimmune Disease Therapeutics Business (2019-2024)

11.1.5 Pfizer Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Autoimmune Disease Therapeutics Introduction

11.2.4 Novartis Revenue in Autoimmune Disease Therapeutics Business (2019-2024)

11.2.5 Novartis Recent Development

11.3 Johnson & Johnson Services

11.3.1 Johnson & Johnson Services Company Detail

11.3.2 Johnson & Johnson Services Business Overview

11.3.3 Johnson & Johnson Services Autoimmune Disease Therapeutics Introduction

11.3.4 Johnson & Johnson Services Revenue in Autoimmune Disease Therapeutics Business (2019-2024)

11.3.5 Johnson & Johnson Services Recent Development

11.4 Merck

11.4.1 Merck Company Detail

11.4.2 Merck Business Overview

11.4.3 Merck Autoimmune Disease Therapeutics Introduction

11.4.4 Merck Revenue in Autoimmune Disease Therapeutics Business (2019-2024)

11.4.5 Merck Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Detail

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Autoimmune Disease Therapeutics Introduction

11.5.4 Sanofi Revenue in Autoimmune Disease Therapeutics Business (2019-2024)

11.5.5 Sanofi Recent Development

11.6 Abott

11.6.1 Abott Company Detail

11.6.2 Abott Business Overview

11.6.3 Abott Autoimmune Disease Therapeutics Introduction

11.6.4 Abott Revenue in Autoimmune Disease Therapeutics Business (2019-2024)

11.6.5 Abott Recent Development

11.7 Bristol-Myers Squibb

11.7.1 Bristol-Myers Squibb Company Detail

11.7.2 Bristol-Myers Squibb Business Overview

11.7.3 Bristol-Myers Squibb Autoimmune Disease Therapeutics Introduction

11.7.4 Bristol-Myers Squibb Revenue in Autoimmune Disease Therapeutics Business (2019-2024)

11.7.5 Bristol-Myers Squibb Recent Development

11.8 Amgen

11.8.1 Amgen Company Detail

11.8.2 Amgen Business Overview

11.8.3 Amgen Autoimmune Disease Therapeutics Introduction

11.8.4 Amgen Revenue in Autoimmune Disease Therapeutics Business (2019-2024)

11.8.5 Amgen Recent Development

11.9 Bayer

11.9.1 Bayer Company Detail

11.9.2 Bayer Business Overview

11.9.3 Bayer Autoimmune Disease Therapeutics Introduction

11.9.4 Bayer Revenue in Autoimmune Disease Therapeutics Business (2019-2024)

11.9.5 Bayer Recent Development

11.10 F. Hoffmann-La Roche

11.10.1 F. Hoffmann-La Roche Company Detail

11.10.2 F. Hoffmann-La Roche Business Overview

11.10.3 F. Hoffmann-La Roche Autoimmune Disease Therapeutics Introduction

11.10.4 F. Hoffmann-La Roche Revenue in Autoimmune Disease Therapeutics Business (2019-2024)

11.10.5 F. Hoffmann-La Roche Recent Development

11.11 Eli Lilly and Company

11.11.1 Eli Lilly and Company Company Detail

11.11.2 Eli Lilly and Company Business Overview

11.11.3 Eli Lilly and Company Autoimmune Disease Therapeutics Introduction

11.11.4 Eli Lilly and Company Revenue in Autoimmune Disease Therapeutics Business (2019-2024)

11.11.5 Eli Lilly and Company Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pfizer Inc

Novartis

Johnson & Johnson Services

Eli Lilly and Company

List of Tables

Table 1. Global Autoimmune Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Immunosuppressants

Table 3. Key Players of Anti-Inflammatory Drugs

Table 4. Key Players of Corticosteroids

Table 5. Key Players of Nonsteroidal Anti-inflammatory Drugs

Table 6. Key Players of Biologics

Table 7. Key Players of Others

Table 8. Global Autoimmune Disease Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Autoimmune Disease Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Autoimmune Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Autoimmune Disease Therapeutics Market Share by Region (2019-2024)

Table 12. Global Autoimmune Disease Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Autoimmune Disease Therapeutics Market Share by Region (2025-2030)

Table 14. Autoimmune Disease Therapeutics Market Trends

Table 15. Autoimmune Disease Therapeutics Market Drivers

Table 16. Autoimmune Disease Therapeutics Market Challenges

Table 17. Autoimmune Disease Therapeutics Market Restraints

Table 18. Global Autoimmune Disease Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Autoimmune Disease Therapeutics Market Share by Players (2019-2024)

Table 20. Global Top Autoimmune Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Therapeutics as of 2023)

Table 21. Ranking of Global Top Autoimmune Disease Therapeutics Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Autoimmune Disease Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Autoimmune Disease Therapeutics Product Solution and Service

Table 25. Date of Enter into Autoimmune Disease Therapeutics Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Autoimmune Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Autoimmune Disease Therapeutics Revenue Market Share by Type (2019-2024)

Table 29. Global Autoimmune Disease Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Autoimmune Disease Therapeutics Revenue Market Share by Type (2025-2030)

Table 31. Global Autoimmune Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Autoimmune Disease Therapeutics Revenue Market Share by Application (2019-2024)

Table 33. Global Autoimmune Disease Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Autoimmune Disease Therapeutics Revenue Market Share by Application (2025-2030)

Table 35. North America Autoimmune Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Autoimmune Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Autoimmune Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Autoimmune Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Autoimmune Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Autoimmune Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Autoimmune Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Autoimmune Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Autoimmune Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Autoimmune Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Autoimmune Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 50. Pfizer Company Detail

Table 51. Pfizer Business Overview

Table 52. Pfizer Autoimmune Disease Therapeutics Product

Table 53. Pfizer Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 54. Pfizer Recent Development

Table 55. Novartis Company Detail

Table 56. Novartis Business Overview

Table 57. Novartis Autoimmune Disease Therapeutics Product

Table 58. Novartis Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 59. Novartis Recent Development

Table 60. Johnson & Johnson Services Company Detail

Table 61. Johnson & Johnson Services Business Overview

Table 62. Johnson & Johnson Services Autoimmune Disease Therapeutics Product

Table 63. Johnson & Johnson Services Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 64. Johnson & Johnson Services Recent Development

Table 65. Merck Company Detail

Table 66. Merck Business Overview

Table 67. Merck Autoimmune Disease Therapeutics Product

Table 68. Merck Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 69. Merck Recent Development

Table 70. Sanofi Company Detail

Table 71. Sanofi Business Overview

Table 72. Sanofi Autoimmune Disease Therapeutics Product

Table 73. Sanofi Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 74. Sanofi Recent Development

Table 75. Abott Company Detail

Table 76. Abott Business Overview

Table 77. Abott Autoimmune Disease Therapeutics Product

Table 78. Abott Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 79. Abott Recent Development

Table 80. Bristol-Myers Squibb Company Detail

Table 81. Bristol-Myers Squibb Business Overview

Table 82. Bristol-Myers Squibb Autoimmune Disease Therapeutics Product

Table 83. Bristol-Myers Squibb Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 84. Bristol-Myers Squibb Recent Development

Table 85. Amgen Company Detail

Table 86. Amgen Business Overview

Table 87. Amgen Autoimmune Disease Therapeutics Product

Table 88. Amgen Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 89. Amgen Recent Development

Table 90. Bayer Company Detail

Table 91. Bayer Business Overview

Table 92. Bayer Autoimmune Disease Therapeutics Product

Table 93. Bayer Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 94. Bayer Recent Development

Table 95. F. Hoffmann-La Roche Company Detail

Table 96. F. Hoffmann-La Roche Business Overview

Table 97. F. Hoffmann-La Roche Autoimmune Disease Therapeutics Product

Table 98. F. Hoffmann-La Roche Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 99. F. Hoffmann-La Roche Recent Development

Table 100. Eli Lilly and Company Company Detail

Table 101. Eli Lilly and Company Business Overview

Table 102. Eli Lilly and Company Autoimmune Disease Therapeutics Product

Table 103. Eli Lilly and Company Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 104. Eli Lilly and Company Recent Development

Table 105. Research Programs/Design for This Report

Table 106. Key Data Information from Secondary Sources

Table 107. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Autoimmune Disease Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Autoimmune Disease Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Immunosuppressants Features

Figure 4. Anti-Inflammatory Drugs Features

Figure 5. Corticosteroids Features

Figure 6. Nonsteroidal Anti-inflammatory Drugs Features

Figure 7. Biologics Features

Figure 8. Others Features

Figure 9. Global Autoimmune Disease Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Autoimmune Disease Therapeutics Market Share by Application: 2023 VS 2030

Figure 11. Hospitals Case Studies

Figure 12. Clinics Case Studies

Figure 13. Independent Pharmacies Case Studies

Figure 14. Others Case Studies

Figure 15. Autoimmune Disease Therapeutics Report Years Considered

Figure 16. Global Autoimmune Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Autoimmune Disease Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Autoimmune Disease Therapeutics Market Share by Region: 2023 VS 2030

Figure 19. Global Autoimmune Disease Therapeutics Market Share by Players in 2023

Figure 20. Global Top Autoimmune Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Therapeutics as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Autoimmune Disease Therapeutics Revenue in 2023

Figure 22. North America Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Autoimmune Disease Therapeutics Market Share by Country (2019-2030)

Figure 24. United States Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Autoimmune Disease Therapeutics Market Share by Country (2019-2030)

Figure 28. Germany Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Autoimmune Disease Therapeutics Market Share by Region (2019-2030)

Figure 36. China Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Japan Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. South Korea Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. India Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Australia Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Autoimmune Disease Therapeutics Market Share by Country (2019-2030)

Figure 44. Mexico Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Brazil Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Autoimmune Disease Therapeutics Market Share by Country (2019-2030)

Figure 48. Turkey Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Pfizer Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)

Figure 51. Novartis Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)

Figure 52. Johnson & Johnson Services Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)

Figure 53. Merck Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)

Figure 54. Sanofi Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)

Figure 55. Abott Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)

Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)

Figure 57. Amgen Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)

Figure 58. Bayer Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)

Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)

Figure 60. Eli Lilly and Company Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions